Kevin Herde
Executive Vice President and Chief Financial Officer (CFO) @Maravai LifeSciences
Signup · Get unlimited contacts
WORK HISTORY
Executive Vice President and Chief Financial Officer (CFO) @Maravai LifeSciences
San Diego, CA, US
Responsible for oversight and leadership of the finance, accounting, tax, treasury, legal, supply chain, information technology, and lender/investor relations activities for Maravai LifeSciences and all of Maravai\'s acquired companies. Maravai LifeSciences trades on the NASDAQ as \"MRVI\" after going public in November 2020 with a $1.9 billion IPO. Maravai currently is a $900M+ revenue company with over 550 employees and a market cap exceeding $7 billion. Maravai enables the miracles of science and improves the human condition through its portfolio of market-leading companies and patented technologies. Biomedical innovation is dependent on a reliable supply of reagents in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, and protein labeling. Maravai LifeSciences operates in two segments: 1) Nucleic Acid Production- RNA synthesis and scale up, including mRNA production, yield-enhancing proprietary CleanCap® mRNA capping technology, and CDMO services ranging from research to GMP grades. Additionally, as a supplier of specialty reagents for DNA and RNA oligonucleotide synthesis for a broad range of applications; and 2) Biologics Safety Testing- leading supplier of kits and services for bioprocess impurity detection, process-related impurity analytics and viral clearance prior to human trials, regulatory approval and commercial release. Founded in 2014 and headquartered in San Diego, Maravai LifeSciences is online at
EDUCATION
University of San Diego
BBA, Bachelor in Business Adminstration
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.